病毒性心肌炎死亡的法医学鉴定
摘要
关键词
全文:
PDF参考
Jr CL, Berry G J, Shabetai R. Idiopathic giant-cell myocarditis— Natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators[J].New England Journal of Medici ne,1997,336(26):1860-1866.
Amabile N, Fraisse A, Bouvenot J, et al. Outcome of acute fulminant myocarditis in children[J]. Heart,2006,92(9):1269-1273. [3] Inaba O, Satoh Y, Isobe M, et al. Factors and values at admission that predict a fulminant course of acute myocarditis: data from Tokyo CCU network database[J].Heart & Vessels,2017(4):1-8.
Nakashima H, Katayama T, Ishizaki M, et al. Q wave and non-Q wave myocarditis with special reference to clinical significance[J]. Japanese Heart Journal,1998,39(6):763-774.
Kim K S, Hufnagel G, Chapman N M, et al. The group B coxsackieviruses and myocarditis[J].Rev Med Virol,2001, 11(6):355-368.
陈雪娇.病毒性心肌炎发病机制的研究进展[J].西南军医, 2012,14(2):294-295.
吴文佑.病毒性心肌炎的诊治进展[J].现代诊断与治疗,2012, 23(4):376-377.
Heidecker B, Kittleson M M, Kasper E K, et al. Transcriptomic biomarkers for the accurate diagnosis of myocarditis[J].Circulation, 2011,123(11):1174-1184.
DOI: https://doi.org/10.12346/pmr.v3i6.4886
Refbacks
- 当前没有refback。